End-systolic dimension
End-systolic dimension (ESD) is a measurement used in cardiology to assess the size of the left ventricle of the heart at the end of its contraction, or systole. This measurement is typically obtained through echocardiography, a diagnostic test that uses ultrasound waves to create images of the heart.
Overview[edit | edit source]
The end-systolic dimension is an important parameter in the evaluation of cardiac function. It provides information about the contractile function of the heart, as it reflects the smallest size the left ventricle achieves during the cardiac cycle. An increased ESD can indicate a decrease in the heart's ability to pump blood effectively, which can be a sign of conditions such as heart failure or dilated cardiomyopathy.
Measurement[edit | edit source]
The end-systolic dimension is typically measured in millimeters (mm) using two-dimensional echocardiography. The measurement is taken from the inner edge of the septum to the inner edge of the posterior wall of the left ventricle at the end of systole. This is often referred to as the "inner edge to inner edge" method.
Clinical significance[edit | edit source]
An increased end-systolic dimension can be indicative of several cardiac conditions. These include:
- Heart failure: This is a condition in which the heart is unable to pump enough blood to meet the body's needs. An increased ESD can be a sign of left ventricular systolic dysfunction, a common cause of heart failure.
- Dilated cardiomyopathy: This is a disease of the heart muscle that causes the left ventricle to enlarge and weaken, leading to heart failure. An increased ESD is a common finding in this condition.
- Ischemic heart disease: This is a condition in which the blood supply to the heart is reduced, often due to atherosclerosis. An increased ESD can be a sign of left ventricular remodeling, a process that occurs in response to myocardial ischemia.
See also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD